MARKET

VERU

VERU

Veru
NASDAQ
1.330
+0.055
+4.30%
Opening 09:37 04/24 EDT
OPEN
1.300
PREV CLOSE
1.275
HIGH
1.380
LOW
1.300
VOLUME
101.69K
TURNOVER
0
52 WEEK HIGH
1.920
52 WEEK LOW
0.3600
MARKET CAP
194.66M
P/E (TTM)
-1.7544
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at VERU last week (0415-0419)?
Weekly Report · 2d ago
LI, VERU and MRIN among pre-market losers
Seeking Alpha · 5d ago
Veru, EyePoint Pharmaceuticals, SINTX Technologies among healthcare movers
Seeking Alpha · 6d ago
What Makes Veru (VERU) a New Buy Stock
NASDAQ · 04/17 16:00
3 Standout Penny Stocks to Watch This April
Penny stocks are stocks that trade for less than $5 per share. Ocugen, Inc. (OCGN), Veru Inc (VERU), and Desktop Metal, Inc (DM) are three outperforming penny stocks trading under $2. Veru Veru stock has surged 82.6% on a YTD basis, but is 31% below its 52-week high.
Barchart · 04/16 12:34
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. The company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome. Soligenix, Inc. Shares surged 71.5% after the company was granted orphan drug designation for MarVax.
Benzinga · 04/15 18:11
VERU <VERU.O>: OPPENHEIMER CUTS TARGET PRICE TO $5 FROM $7
Reuters · 04/15 13:06
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Wells Fargo boosted the price target for Centene Corporation from $89 to $93. Charter Communications, Inc. And Notable Labs, Ltd. Also saw their price targets cut. The price target of Veru Inc. Was slashed from $7 to $5.
Benzinga · 04/15 12:39
More
About VERU
Veru Inc. is a biopharmaceutical company. The Company is focused on developing medicines for the for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the management of breast and prostate cancers. The Company offers two FDA approved products within its sexual health program, including ENTADFI (tadalafil 5mg and finasteride 5mg capsule), for the treatment of benign prostatic hyperplasia and FC2 Female Condom (internal condom) (FC2), for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. Its breast cancer drug pipeline has four clinical development programs for two drugs, such as enobosarm, an oral selective androgen receptor targeting agonist, and sabizabulin, an oral cytoskeleton disruptor. Its prostate cancer drug pipeline includes sabizabulin, VERU-100 and zuclomiphene citrate.

Webull offers Veru Inc stock information, including NASDAQ: VERU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VERU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VERU stock methods without spending real money on the virtual paper trading platform.